Most of the funds going to insiders by the looks.2 hours reading...

Most of the funds going to insiders by the looks.

2 hours reading that thing. few outstanding patents have been filed. Currently investing a gmp partner which is interesting. Seem to have the backing of the warf which should prove fruitful. Sluvkin was the man behind the scenes @ cynata along with a chap named Ian Dixon.

I note that there are royalty payments channelled to the warf on every commercially successful good from their stable licensed to cynata.

Expect delisting around the 29th and then 2014 should see things get a little more serious.

The scaleabilty and non marrow nature of their cells looks very interesting (ipc's). They have set this one up for multiple trial/end points.

I expect partners down the track here my 2c